Dr Samir'S Ganga Diagnostic And Imaging Centre Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.84 M
as on 24-10-2024
- Revenue 55.95%
(FY 2023)
- Profit 1034.21%
(FY 2023)
- Ebitda 160.00%
(FY 2023)
- Net Worth 489.54%
(FY 2023)
- Total Assets 3.77%
(FY 2023)
About Dr Samir'S Ganga Diagnostic And Imaging Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹9.84 M.
Samir Upadhyay and Tanjul Vashist serve as directors at the Company.
- CIN/LLPIN
U85122DL2017PTC315773
- Company No.
315773
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Apr 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Dr Samir'S Ganga Diagnostic And Imaging Centre?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samir Upadhyay  | Director | 07-Apr-2017 | Current |
| Tanjul Vashist | Director | 07-Apr-2017 | Current |
Financial Performance of Dr Samir'S Ganga Diagnostic And Imaging Centre.
Dr Samir'S Ganga Diagnostic And Imaging Centre Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 55.95% increase. The company also saw a substantial improvement in profitability, with a 1034.21% increase in profit. The company's net worth Soared by an impressive increase of 489.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr Samir'S Ganga Diagnostic And Imaging Centre?
In 2023, Dr Samir'S Ganga Diagnostic And Imaging Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Oct 2021 | ₹5.00 M | Open |
Axis Bank Limited Creation Date: 15 Jan 2021 | ₹4.84 M | Open |
How Many Employees Work at Dr Samir'S Ganga Diagnostic And Imaging Centre?
Unlock and access historical data on people associated with Dr Samir'S Ganga Diagnostic And Imaging Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr Samir'S Ganga Diagnostic And Imaging Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr Samir'S Ganga Diagnostic And Imaging Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
